5th Dec 2007 17:00
AstraZeneca PLC05 December 2007 Transaction by Persons Discharging Managerial Responsibilities Disclosure Rules DR 3.1.4R We hereby inform you that AstraZeneca PLC has received notice under DTR 3.1.2Rthat, on 30 November 2007, David Mott, President and Chief Executive Officer ofMedImmune Inc., a person discharging managerial responsibilities, was awarded59,435 AstraZeneca American Depositary Shares (ADSs) under the terms of theAstraZeneca Pharmaceuticals LP Restricted Stock Unit Award Plan at an awardprice of USD47.11 per ADS. One ADS equals one Ordinary Share. The award isexpected to vest on 18 June 2009 subject to the rules of the Plan at which timeMr Mott will become beneficially entitled to the 59,435 ADSs providing that heremains in employment until that time. G H R Musker Company Secretary 5 December 2007 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca